Redefining Heart Failure in Breast Cancer

por Volgman, Annabelle Santos, Brezden-Masley, Christine, Okwuosa, Tochi
Publicado 2022

Cancer and Cardiovascular Disease: The Complex Labyrinth

por Dent, Susan, Liu, Peter, Brezden-Masley, Christine, Lenihan, Daniel
Publicado 2015

Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma – significance of potentially retained stemness

por Yoon, Ju-Yoon, Brezden-Masley, Christine, Streutker, Catherine J.
Publicado 2020

Autophagic Heterogeneity in Gastric Adenocarcinoma

por Yoon, Ju-Yoon, Brezden-Masley, Christine, Streutker, Catherine J.
Publicado 2021

Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population

por Abadir, Amir, Streutker, Catherine, Brezden-Masley, Christine, Grin, Andrea, Kim, Young-In
Publicado 2012

Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study

por Yoon, Ju-Yoon, Sy, Keiyan, Brezden-Masley, Christine, Streutker, Catherine J.
Publicado 2019

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective

por Ferrario, Cristiano, Christofides, Anna, Joy, Anil Abraham, Laing, Kara, Gelmon, Karen, Brezden-Masley, Christine
Publicado 2022

Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer

por Simmons, Christine E., Brezden-Masley, Christine, McCarthy, Joy, McLeod, Deanna, Joy, Anil Abraham
Publicado 2020

The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based R...

por Sue-Chue-Lam, Colin, Brezden-Masley, Christine, Sutradhar, Rinku, Yu, Amy Y. X., Baxter, Nancy N.
Publicado 2023

A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer

por Brezden‐Masley, Christine, Fathers, Kelly E., Coombes, Megan E., Pourmirza, Behin, Xue, Cloris, Jerzak, Katarzyna J.
Publicado 2020

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

por O’Shaughnessy, Joyce, Brezden-Masley, Christine, Cazzaniga, Marina, Dalvi, Tapashi, Walker, Graham, Bennett, James, Ohsumi, Shozo
Publicado 2020

A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer

por Brezden-Masley, Christine, Fathers, Kelly E., Coombes, Megan E., Pourmirza, Behin, Xue, Cloris, Jerzak, Katarzyna J.
Publicado 2020

A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer

por Brezden-Masley, Christine, Fathers, Kelly E., Coombes, Megan E., Pourmirza, Behin, Xue, Cloris, Jerzak, Katarzyna J.
Publicado 2020

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

por Yang, Charlie, Brezden-Masley, Christine, Joy, Anil Abraham, Sehdev, Sandeep, Modi, Shanu, Simmons, Christine, Henning, Jan-Willem
Publicado 2023

Clinicians’ Perspectives on Barriers to Discussing Infertility and Fertility Preservation With Young Women With Cancer

por Covelli, Andrea, Facey, Marcia, Kennedy, Erin, Brezden-Masley, Christine, Gupta, Abha A., Greenblatt, Ellen, Baxter, Nancy N.
Publicado 2019

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc...

por Rayson, Daniel, Gandhi, Sonal, Joy, Anil A., Brezden-Masley, Christine, Gelmon, Karen A., Sehdev, Sandeep, Cescon, David, Chia, Stephen
Publicado 2023

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective

por Henning, Jan-Willem, Brezden-Masley, Christine, Gelmon, Karen, Chia, Stephen, Shapera, Shane, McInnis, Micheal, Rayson, Daniel, Asselah, Jamil
Publicado 2023

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis

por Wilson, Florence R., Coombes, Megan E., Wylie, Quinlan, Yurchenko, Mariya, Brezden-Masley, Christine, Hutton, Brian, Skidmore, Becky, Cameron, Chris
Publicado 2017

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain

por Rayson, Daniel, Gandhi, Sonal, Joy, Anil A., Brezden-Masley, Christine, Gelmon, Karen A., Sehdev, Sandeep, Cescon, David, Chia, Stephen
Publicado 2022

HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review

por Jerzak, Katarzyna J., Bouganim, Nathaniel, Brezden-Masley, Christine, Edwards, Scott, Gelmon, Karen, Henning, Jan-Willem, Hilton, John F., Sehdev, Sandeep
Publicado 2023